IP Library Granted Patent US 9,074,199
Granted Patent B1
US 9,074,199 · App. 14/319,784 · Granted Jul 7, 2015

Mutant Cas9 proteins

Inventors: Alejandro Chavez (Brookline, MA); Frank Poelwijk (Dallas, TX); George M. Church (Brookline, MA)
Assignee: President and Fellows of Harvard College
C12N9/22
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,074,199
App. No.
14/319,784
Granted
Jul 7, 2015
Kind
B1
Abstract

Methods of making mutant Cas9 proteins are described.

Claims (14)

1. A method of making a mutant Cas9 protein having DNA binding activity comprising

aligning full length amino acid sequences of a family of Cas9 proteins,

identifying one or more diverging amino acid sequence portions among the full length amino acid sequences of the family of Cas9 proteins,

identifying a nucleic acid sequence for the one or more diverging amino acid sequences portions,

generating a nucleic acid sequence for a target Cas9 protein which lacks the nucleic acid sequence for the one or more diverging amino acid sequences portions, and

generating a mutant Cas9 protein from the generated nucleic acid sequence.

2. The method of claim 1 wherein the target Cas9 protein has nuclease activity.

3. The method of claim 1 wherein the target Cas9 protein is a nickase.

4. The method of claim 1 wherein the target Cas9 protein is nuclease null.

5. The method of claim 1 wherein the nucleic acid sequence encoding the one or more diverging amino acid sequences portions is deleted from a nucleic acid sequence encoding a full length Cas9 protein.

6. The method of claim 1 wherein the nucleic acid sequence encoding the one or more diverging amino acid sequences portions is deleted from a nucleic acid sequence encoding a full length Cas9 protein and replaced with a linker.

7. The method of claim 1 wherein the nucleic acid sequence encoding the one or more diverging amino acid sequences portions is deleted from a nucleic acid sequence encoding the target Cas9 protein and replaced with a SGGGS linker.

8. The method of claim 1 wherein the mutant Cas9 protein is a mutant Cas9 protein encoded by the nucleic acid sequence of SEQ ID NO:1.

9. The method of claim 1 wherein the mutant Cas9 protein is a mutant Cas9 protein encoded by the nucleic acid sequence of SEQ ID NO:2.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 18, 2014
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034282/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2014
From: CHAVEZ, ALEJANDRO; CHURCH, GEORGE M.; POELWIJK, FRANK J.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 034096/0009 →
Continuity (1)
Provisional Application 61906374 · Nov 19, 2013